Experts Discuss Evolving State-of-the-Art Management of Patients With HER2-Positive MBC

Decera Clinical Education Oncology Podcast · Sep 21, 2020 · 11m

In this podcast episode, listen to breast cancer experts Thomas Bachelot, MD, PhD; Adam M. Brufsky, MD, PhD; and Cristina Saura, MD, PhD, discuss clinical considerations for patients with HER2-positive MBC, with topics including:

Local therapy in the context of MBC

Choice of therapy after progression on available standards of care

Choice of trastuzumab deruxtecan and tucatinib based on patient presentation

Managing patients with CNS metastases

Managing interstitial lung disease

Presenters:

Thomas Bachelot, MD, PhD

Chair, Unicancer Breast Group - UCBG

Breast Cancer Unit

Medical Oncology

Centre…